Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
27
GMRE Quote, Financials, Valuation and Earnings
Last price:
$33.91
Seasonality move
:
1017.07%
Day range:
$33.47 - $34.00
52-week range:
$29.05 - $45.75
Dividend yield:
9.78%
P/E ratio:
312.68x
P/S ratio:
8.53x
P/B ratio:
1.10x
Volume:
92.1K
Avg. volume:
140.1K
1-year change:
-12.59%
Market cap:
$452.4M
Revenue:
$156M
EPS (TTM):
-$0.37
Analysts' Opinion
-
Consensus RatingGlobal Medical REIT, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $42.31, Global Medical REIT, Inc. has an estimated upside of 25.39% from its current price of $33.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $35.00 representing 100% downside risk from its current price of $33.74.
Fair Value
-
According to the consensus of 8 analysts, Global Medical REIT, Inc. has 25.39% upside to fair value with a price target of $42.31 per share.
GMRE vs. S&P 500
-
Over the past 5 trading days, Global Medical REIT, Inc. has overperformed the S&P 500 by 3.63% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Global Medical REIT, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Global Medical REIT, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Global Medical REIT, Inc. reported revenues of $40.6M.
Earnings Growth
-
Global Medical REIT, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Global Medical REIT, Inc. reported earnings per share of -$0.45.
Enterprise value:
1.3B
EV / Invested capital:
--
Price / LTM sales:
8.53x
EV / EBIT:
26.76x
EV / Revenue:
7.98x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-21.21x
Price / Operating cash flow:
24.65x
Enterprise value / EBITDA:
12.05x
Gross Profit (TTM):
$69.7M
Return On Assets:
0.17%
Net Income Margin (TTM):
1.39%
Return On Equity:
0.41%
Return On Invested Capital:
0.18%
Operating Margin:
30.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $157.5M | $154.5M | $158.7M | $38.8M | $40.6M | |
| Gross Profit | $69.4M | $70.3M | $69.7M | $17.7M | $17.3M | |
| Operating Income | $52.6M | $52.7M | $47.3M | $13.3M | $12.5M | |
| EBITDA | $111.6M | $108.7M | $105.1M | $27M | $27.5M | |
| Diluted EPS | $0.24 | -$0.02 | -$0.37 | $0.03 | -$0.45 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $47.6M | $56.4M | $51.8M | $35.7M | $47.5M | |
| Total Assets | $1.2B | $1.4B | $1.3B | $1.2B | $1.3B | |
| Current Liabilities | $26.6M | $34.6M | $33.6M | $33.1M | $33.4M | |
| Total Liabilities | $613.1M | $742.2M | $668.9M | $678M | $767.4M | |
| Total Equity | $630.2M | $664.6M | $633.6M | $564.6M | $505.8M | |
| Total Debt | $562.9M | $704.1M | $631.1M | $640.1M | $728.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $68.6M | $67.6M | $72.5M | $16.3M | $17.6M | |
| Cash From Investing | $67.7M | -$21.1M | -$86.7M | -$25.5M | -$703K | |
| Cash From Financing | -$142.3M | -$46.4M | $16.2M | $9.2M | -$16.2M | |
| Free Cash Flow | $60.5M | $22.6M | -$59.7M | -$19.7M | $14.3M | |
GMRE
Sector
Market Cap
$452.4M
$974.8M
Price % of 52-Week High
73.75%
86.99%
Dividend Yield
9.78%
2.45%
Shareholder Yield
6.12%
3.12%
1-Year Price Total Return
-12.59%
--
Beta (5-Year)
1.182
0.628
Dividend yield:
9.78%
Annualized payout:
$4.20
Payout ratio:
-622.86%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$33.65
200-day SMA
Sell
Level
$34.76
Bollinger Bands (100)
Sell
Level
31.55 - 36.19
Chaikin Money Flow
Sell
Level
-4.9M
20-day SMA
Sell
Level
$34.07
Relative Strength Index (RSI14)
Buy
Level
50.71
ADX Line
Buy
Level
16.57
Williams %R
Neutral
Level
-71.0345
50-day SMA
Buy
Level
$32.82
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-6.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4307)
Sell
CA Score
(Annual)
Level (-0.501)
Buy
Beneish M-Score
(Annual)
Level (-3.5082)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.002)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Stock Forecast FAQ
In the current month, GMRE has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The GMRE average analyst price target in the past 3 months is $42.31.
-
Where Will Global Medical REIT, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Global Medical REIT, Inc. share price will rise to $42.31 per share over the next 12 months.
-
What Do Analysts Say About Global Medical REIT, Inc.?
Analysts are divided on their view about Global Medical REIT, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Global Medical REIT, Inc. is a Sell and believe this share price will drop from its current level to $35.00.
-
What Is Global Medical REIT, Inc.'s Price Target?
The price target for Global Medical REIT, Inc. over the next 1-year time period is forecast to be $42.31 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is GMRE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Global Medical REIT, Inc. is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of GMRE?
You can purchase shares of Global Medical REIT, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Global Medical REIT, Inc. shares.
-
What Is The Global Medical REIT, Inc. Share Price Today?
Global Medical REIT, Inc. was last trading at $33.91 per share. This represents the most recent stock quote for Global Medical REIT, Inc.. Yesterday, Global Medical REIT, Inc. closed at $33.74 per share.
-
How To Buy Global Medical REIT, Inc. Stock Online?
In order to purchase Global Medical REIT, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GMRE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GMRE
Sector
P/E ratio
312.68x
17.33x
PEG ratio
-0.06x
0.05x
P/B ratio
1.10x
0.82x
Price / LTM sales
8.53x
3.14x
Growth Metrics
GMRE
Sector
Revenue growth
4.62%
3.18%
Earnings growth
-1747.43%
6.29%
Revenue (5-year growth)
17.14%
2.86%
Earnings forecast
$0.13
$0.14
Profitability
GMRE
Sector
Profitability FY 2024
$71.4M
$154.7M
Return on invested capital
0.18%
2.03%
Return on assets
0.17%
1.83%
Return on equity
0.41%
3.5%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
3
Balance Sheet
GMRE
Sector
Total cash
$10.4M
$73.8M
Short term investments
--
$11.9M
Total assets
$1.3B
$3.2B
Long term debt
$728.4M
$349.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
45
CTEV alert for Jan 2
Claritev Corp. [CTEV] is down 20.7% over the past day.
Sell
47
ASTS alert for Jan 2
AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.
Sell
45
BIDU alert for Jan 2
Baidu, Inc. [BIDU] is up 15.01% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
